Abstract
Background: Recent findings suggest that dopaminergic abnormalities found in psychotic disorders may be secondary to nitric oxide dysfunctions. Nitric oxide seems to influence glutamatergic and dopaminergic neurotransmission, both of which have been associated with psychosis. Objective: To search and review published works which examined the influence of nitric oxide in psychotic disorders subjects. Method: The research was executed in the on-line collections of Pubmed and ISI Web of Science. The key aspects utilized were “Psychotic Disorders AND Nitric Oxide”, “Psychosis AND Nitric Oxide”,“Schizotypal Personality Disorder AND Nitric Oxide”, “Delusional Disorder AND Nitric Oxide”, “Brief Psychotic Disorder AND Nitric Oxide”, “Schizophreniform Disorder AND Nitric Oxide”, “Schizoaffective Disorder AND Nitric Oxide”, and “Schizophrenia AND Nitric Oxide”. Empirical works utilizing human subjects, published in the last 10 years, in English language were included. Results: Initially, the search yielded a total of 95 studies. Then, 39 were elected according to the inclusion requirements. The selected articles were divided into five groups: biochemical studies (n=15; 38.5%), genetic studies (n=11; 28.2%), postmortem studies (n=6; 15.4%), clinical trials (n=6; 15.4%), and case reports (n=1; 2.5%). The studies evaluated only schizophrenic or schizoaffective disorder subjects. The great majority of them found evidence of nitric oxide dysfunctions in psychosis. Conclusion: The results of the review strengthen the idea that nitric oxide has a key participation in psychotic disorders and deserves deeper investigation as a target for future pharmacological intervention.
Keywords: Nitric Oxide, Nitric Oxide System, Psychosis, Psychotic Disorders, Schizophrenia, Schizoaffective Disorder.
Current Medicinal Chemistry
Title:Nitric Oxide’s Involvement in the Spectrum of Psychotic Disorders
Volume: 23 Issue: 24
Author(s): João Paulo Maia-de-Oliveira, Ludmyla Kandratavicius, Emerson Arcoverde Nunes, João Paulo Machado-de-Sousa, Jaime E. Hallak and Serdar Murat Dursun
Affiliation:
Keywords: Nitric Oxide, Nitric Oxide System, Psychosis, Psychotic Disorders, Schizophrenia, Schizoaffective Disorder.
Abstract: Background: Recent findings suggest that dopaminergic abnormalities found in psychotic disorders may be secondary to nitric oxide dysfunctions. Nitric oxide seems to influence glutamatergic and dopaminergic neurotransmission, both of which have been associated with psychosis. Objective: To search and review published works which examined the influence of nitric oxide in psychotic disorders subjects. Method: The research was executed in the on-line collections of Pubmed and ISI Web of Science. The key aspects utilized were “Psychotic Disorders AND Nitric Oxide”, “Psychosis AND Nitric Oxide”,“Schizotypal Personality Disorder AND Nitric Oxide”, “Delusional Disorder AND Nitric Oxide”, “Brief Psychotic Disorder AND Nitric Oxide”, “Schizophreniform Disorder AND Nitric Oxide”, “Schizoaffective Disorder AND Nitric Oxide”, and “Schizophrenia AND Nitric Oxide”. Empirical works utilizing human subjects, published in the last 10 years, in English language were included. Results: Initially, the search yielded a total of 95 studies. Then, 39 were elected according to the inclusion requirements. The selected articles were divided into five groups: biochemical studies (n=15; 38.5%), genetic studies (n=11; 28.2%), postmortem studies (n=6; 15.4%), clinical trials (n=6; 15.4%), and case reports (n=1; 2.5%). The studies evaluated only schizophrenic or schizoaffective disorder subjects. The great majority of them found evidence of nitric oxide dysfunctions in psychosis. Conclusion: The results of the review strengthen the idea that nitric oxide has a key participation in psychotic disorders and deserves deeper investigation as a target for future pharmacological intervention.
Export Options
About this article
Cite this article as:
Maia-de-Oliveira Paulo João, Kandratavicius Ludmyla, Nunes Arcoverde Emerson, Machado-de-Sousa Paulo João, Hallak E. Jaime and Dursun Murat Serdar, Nitric Oxide’s Involvement in the Spectrum of Psychotic Disorders, Current Medicinal Chemistry 2016; 23 (24) . https://dx.doi.org/10.2174/0929867323666160721144549
DOI https://dx.doi.org/10.2174/0929867323666160721144549 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Genetic Risk Factors for Depression in Alzheimer´s Disease Patients
Current Alzheimer Research Alzheimer's Disease: Related Targets, Synthesis of Available Drugs, Bioactive Compounds Under Development and Promising Results Obtained from Multi-target Approaches
Current Drug Targets Heat Shock Proteins as Suppressors of Accumulation of Toxic Prefibrillar Intermediates and Misfolded Proteins in Neurodegenerative Diseases
Current Pharmaceutical Biotechnology Polyphenols and Depression: from Chemistry to Medicine
Current Pharmaceutical Biotechnology Targeting the Progression of Parkinsons Disease
Current Neuropharmacology HTR2A Gene Variants and Psychiatric Disorders: A Review of Current Literature and Selection of SNPs for Future Studies
Current Medicinal Chemistry Crossed Cerebellar Diaschisis in Alzheimer’s Disease
Current Alzheimer Research High Sensitivity C-Reactive Protein as a Potential Biomarker of Neuroinflammation in Major Psychiatric Disorders
Current Psychiatry Reviews Hippocampal Morphology and Autobiographic Memory in Mild Cognitive Impairment and Alzheimer’s Disease
Current Alzheimer Research Predictors of Cardiovascular Affection in Patients with Active Rheumatoid Arthritis: Secondary Analysis of a Randomized Controlled Trial
Current Rheumatology Reviews Screening for Inhibitors of Tau Protein Aggregation into Alzheimer Paired Helical Filaments: A Ligand Based Approach Results in Successful Scaffold Hopping
Current Alzheimer Research Potentiality of Oxygen-Ozonetherapy to Improve the Health of Aging People
Current Aging Science Parkinson's Disease, Diabetes and Cognitive Impairment
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Structural and Functional MRI in Mild Cognitive Impairment
Current Alzheimer Research Preface: Scope of Current Alzheimer Research Debomoy
Current Alzheimer Research Therapeutic Targets for the Management of Peripheral Nerve Injury- Induced Neuropathic Pain
CNS & Neurological Disorders - Drug Targets Disrupting Self-Assembly and Toxicity of Amyloidogenic Protein Oligomers by “ Molecular Tweezers” - from the Test Tube to Animal Models
Current Pharmaceutical Design Platelet and Soluble Glycoprotein VI - Novel Applications in Diagnosis and Therapy
Current Drug Targets Vitexin with its Derivatives is Responsible for the Cholinomimetic Properties of <i>Penianthus longifolius</i> Extract which Stimulates Muscarinic Receptors
The Natural Products Journal Implication of Oncogenic Signaling Pathways as a Treatment Strategy for Neurodegenerative Disorders – Contemporary Approaches
CNS & Neurological Disorders - Drug Targets